ReviewInternational journal of molecular sciences2017

Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS).

Matteo Ferro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.